[3] People taking the highest dose of the pill lost 8% of their weight, or around 16 lb (7.3 kg), on average after 40 weeks
A reasonable target is 2 to 3 liters of water daily, adjusted upward for physical activity and warm environments
A phase 3 trial of setmelanotide (RM-493), a melanocortin-4 receptor (MC4R) agonist, in Bardet-Biedl Syndrome (BBS) and Alstrom Syndrome (AS) patients with moderate to severe obesity
Consider in Differential Diagnosis: When a patient on a GLP-1 or GIP/GLP-1 medication presents with new-onset neuropathic pain or sensory abnormalities, consider the medication as a potential cause
Dual Board Certified 25+ Yrs Experience Clinical Faculty Elaine Briggs, DNP, FNP-C Nurse Practitioner Primary Care & Telehealth Your go-to for visits, refills, and questions by phone or video